Eleventh Circuit Reverses: FCA Qui Tam Provisions Upheld on Appointments Clause
The Eleventh Circuit held on September 1, 2026 that the False Claims Act's qui tam provisions do not violate the Appointments Clause, reversing a district court that had struck them down.
On September 1, 2026, the U.S. Court of Appeals for the Eleventh Circuit reversed a district court ruling that had declared the False Claims Act's qui tam whistleblower provisions unconstitutional under the Appointments Clause, reinstating the FCA's core enforcement mechanism across much of the Southeast. The significance reaches beyond the circuit's geography: a constitutional attack on the FCA's relator framework has now failed on appeal, which typically discourages further district-court efforts to dismantle the statute's structure and reduces defense leverage for separation-of-powers objections.
For government contractors, healthcare providers, manufacturers, and federal grant recipients the consequences are substantial. FCA qui tam settlements run into the billions of dollars annually, and private relator suits remain the largest single driver of FCA case volume. Defense teams should reassess whether Appointments Clause arguments remain worth preserving in pending matters, given their cost against a statute appellate courts are sustaining.
Two uncertainties matter. The reported summary does not set out the holding's scope, the reasoning, or whether the government sought further review, so durability is unclear. And the decision binds only the Eleventh Circuit, leaving parallel litigation elsewhere unresolved. Watch for certiorari petitions and for Appointments Clause challenges in other circuits. This summarizes reported developments and is not legal advice.